Dosage Hyper Pharma Llp - Company Profile

It is a pharma limited liability partnership based in Kondotty, Kerala, India, established in 2018.
2018 Kondotty, Kerala, India Active
Last Updated:
Access Report
About Dosage Hyper Pharma Llp

Dosage Hyper Pharma Llp, a active limited liability partnership, was established on 25 September 2018 in Kondotty, Kerala, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAN-3432. Registered under ROC Roc Ernakulam. It has total obligation of contribution of ₹2.93 Cr.

Its leadership includes Mohammed (Designated Partner), Faizal Babu Ambalancheeri (Designated Partner). Past directors included Moossakutty, Abdussalam Pulikkal, Thuvakkat Sreenivasan. Its latest date of accounts and solvency statement 31 March 2025. It is based at Room No.9/2290,2291 Near Mdc Bank Bypass Junction,, Kondotty, Kerala, 673638.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAN-3432

  • Incorporation Date

    25 September 2018

  • Total Obligation of Contribution

    ₹2.93 Cr

  • ROC Code

    Roc Ernakulam

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 2.93 Cr
  • Company Age 7 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Dosage Hyper Pharma Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Dosage Hyper Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Dosage Hyper Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Mohammed Designated Partner 25 Sep 2018 Current
Faizal Babu Ambalancheeri Designated Partner 10 May 2023 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Designated Partner 10 May 2023 Past
Pramod Abcsdd Partner - Past
Pramod Abcsdd Partner - Past
Pramod Abcsdd Partner - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dosage Hyper Pharma Llp.

Enhance accessibility to Dosage Hyper Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Dosage Hyper Pharma Llp revenue growth over time
Dosage Hyper Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dosage Hyper Pharma Llp?

Unlock access to Dosage Hyper Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Dosage Hyper Pharma Llp?

Unlock and access historical data on people associated with Dosage Hyper Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dosage Hyper Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dosage Hyper Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dosage Hyper Pharma Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Dosage Hyper Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    Progress on Dosage Hyper Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam. was documented.

  • Director Appointment

    Progress on Faizal Babu Ambalancheeri was appointed as a Designated Partner was appointed as a Designated Partner on 10 May 2023 & has been associated with this company since 2 years 10 months . was documented.

  • Director Appointment

    Progress on Mohammed was appointed as a Designated Partner was appointed as a Designated Partner on 25 Sep 2018 & has been associated with this company since 7 years 6 months . was documented.

  • LLP Incorporation

    Progress on Dosage Hyper Pharma Llp was registered on 25 Sep 2018 with Roc Ernakulam & aged 7 years 6 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Dosage Hyper Pharma Llp?

The LLPIN of Dosage Hyper Pharma Llp is AAN-3432.

Where is Dosage Hyper Pharma Llp headquartered?

Dosage Hyper Pharma Llp is headquartered at Room No.9/2290,2291 Near Mdc Bank Bypass Junction,, Kondotty, Kerala, 673638.

When was Dosage Hyper Pharma Llp incorporated?

Dosage Hyper Pharma Llp was incorporated on 25 September 2018.

Who are the current directors of Dosage Hyper Pharma Llp?

The current directors of Dosage Hyper Pharma Llp are

What is the primary industry of Dosage Hyper Pharma Llp?

The primary industry of Dosage Hyper Pharma Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available